JVI Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stevens, A.
Right arrow Articles by Stoye, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stevens, A.
Right arrow Articles by Stoye, J. P.
Journal of Virology, September 2004, p. 9592-9598, Vol. 78, No. 18
0022-538X/04/$08.00+0     DOI: 10.1128/JVI.78.18.9592-9598.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Retroviral Capsid Determinants of Fv1 NB and NR Tropism

Anthony Stevens,1,{dagger} Michael Bock,1,{dagger},{ddagger} Scott Ellis,1,§ Paul LeTissier,1 Kate N. Bishop,1,|| Melvyn W. Yap,1 Willie Taylor,2 and Jonathan P. Stoye1*

Divisions of Virology,1 Mathematical Biology, National Institute for Medical Research, London, United Kingdom2

Received 17 February 2004/ Accepted 10 May 2004

The specificity determinants for susceptibility to resistance by the Fv1 n and b alleles map to amino acid 110 of the murine leukemia virus CA protein. To study the interaction between Fv1 and CA, we examined changes in CA resulting in the loss of susceptibility to Fv1 resistance in naturally occurring NB- and NR-tropic viruses. A variety of amino acid changes affecting Fv1 tropism were identified, at CA positions 82, 92 to 95, 105, 114, and 117, and they all were mapped to the apparent exterior of virion-associated CA. These amino acids may form a binding surface for Fv1.


* Corresponding author. Mailing address: Division of Virology, National Institute for Medical Research, The Ridgeway, Mill Hill, London NW7 1AA, United Kingdom. Phone: 44-208/816-2140, Fax: 44-208/906-4477. E-mail: jstoye{at}nimr.mrc.ac.uk.

{dagger} A.S. and M. B. contributed equally to this study.

{ddagger} Present address: Institut fuer Virologie und Immunbiologie, Universitaet Wuerzburg, 97078 Wuerzburg, Germany.

§ Present address: BHF Molecular Cardiology Laboratory, Wellcome Trust Centre for Molecular Genetics, Headington, Oxford OX3 7BN, United Kingdom.

Present address: Division of Molecular Neuroendocrinology, National Institute for Medical Research, London NW7 1AA, United Kingdom.

|| Present address: Department of Infectious Diseases, Guy's, King's and St. Thomas' Medical School, King's College London, London SE1 9RT, United Kingdom.


Journal of Virology, September 2004, p. 9592-9598, Vol. 78, No. 18
0022-538X/04/$08.00+0     DOI: 10.1128/JVI.78.18.9592-9598.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. Mol. Cell. Biol. Microbiol. Mol. Biol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2004 by the American Society for Microbiology. All rights reserved.